Literature DB >> 16611631

Distinct priming kinases contribute to differential regulation of collapsin response mediator proteins by glycogen synthase kinase-3 in vivo.

Adam R Cole1, Frédéric Causeret, Gokhan Yadirgi, C James Hastie, Hilary McLauchlan, Edward J McManus, Félix Hernández, Britta J Eickholt, Margareta Nikolic, Calum Sutherland.   

Abstract

Collapsin response mediator proteins (CRMPs) are a family of neuron-enriched proteins that regulate neurite outgrowth and growth cone dynamics. Here, we show that Cdk5 phosphorylates CRMP1, CRMP2, and CRMP4, priming for subsequent phosphorylation by GSK3 in vitro. In contrast, DYRK2 phosphorylates and primes CRMP4 only. The Cdk5 and DYRK2 inhibitor purvalanol decreases the phosphorylation of CRMP proteins in neurons, whereas CRMP1 and CRMP2, but not CRMP4, phosphorylation is decreased in Cdk5(-/-) cortices. Stimulation of neuroblastoma cells with IGF1 or TPA decreases GSK3 activity concomitantly with CRMP2 and CRMP4 phosphorylation. Conversely, increased GSK3 activity is not sufficient to increase CRMP phosphorylation. However, the growth cone collapse-inducing protein Sema3A increases Cdk5 activity and promotes phosphorylation of CRMP2 (but not CRMP4). Therefore, inhibition of GSK3 alters phosphorylation of all CRMP isoforms; however, individual isoforms can be differentially regulated by their respective priming kinase. This is the first GSK3 substrate found to be regulated in this manner and may explain the hyperphosphorylation of CRMP2 observed in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16611631      PMCID: PMC1805471          DOI: 10.1074/jbc.M513344200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  CRMP-2 induces axons in cultured hippocampal neurons.

Authors:  N Inagaki; K Chihara; N Arimura; C Ménager; Y Kawano; N Matsuo; T Nishimura; M Amano; K Kaibuchi
Journal:  Nat Neurosci       Date:  2001-08       Impact factor: 24.884

Review 2.  GSK3 takes centre stage more than 20 years after its discovery.

Authors:  S Frame; P Cohen
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

3.  Fyn and Cdk5 mediate semaphorin-3A signaling, which is involved in regulation of dendrite orientation in cerebral cortex.

Authors:  Yukio Sasaki; Chi Cheng; Yutaka Uchida; Oumi Nakajima; Toshio Ohshima; Takeshi Yagi; Masahiko Taniguchi; Takashi Nakayama; Reiji Kishida; Yoshihisa Kudo; Shigeaki Ohno; Fumio Nakamura; Yoshio Goshima
Journal:  Neuron       Date:  2002-08-29       Impact factor: 17.173

4.  Alpha2-chimaerin, cyclin-dependent Kinase 5/p35, and its target collapsin response mediator protein-2 are essential components in semaphorin 3A-induced growth-cone collapse.

Authors:  Matthew Brown; Tom Jacobs; Britta Eickholt; Giovanna Ferrari; Mabel Teo; Clinton Monfries; Robert Z Qi; Thomas Leung; Louis Lim; Christine Hall
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

5.  The specificities of protein kinase inhibitors: an update.

Authors:  Jenny Bain; Hilary McLauchlan; Matthew Elliott; Philip Cohen
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

Review 6.  Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetes.

Authors:  Allan S Wagman; Kirk W Johnson; Dirksen E Bussiere
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

7.  CRMP-2 binds to tubulin heterodimers to promote microtubule assembly.

Authors:  Yuko Fukata; Tomohiko J Itoh; Toshihide Kimura; Céline Ménager; Takashi Nishimura; Takashi Shiromizu; Hiroyasu Watanabe; Naoyuki Inagaki; Akihiro Iwamatsu; Hirokazu Hotani; Kozo Kaibuchi
Journal:  Nat Cell Biol       Date:  2002-08       Impact factor: 28.824

Review 8.  Cdk5 in neuroskeletal dynamics.

Authors:  Deanna Smith
Journal:  Neurosignals       Date:  2003 Sep-Oct

9.  CRMP-2 regulates polarized Numb-mediated endocytosis for axon growth.

Authors:  Takashi Nishimura; Yuko Fukata; Katsuhiro Kato; Tomoya Yamaguchi; Yoshiharu Matsuura; Hiroyuki Kamiguchi; Kozo Kaibuchi
Journal:  Nat Cell Biol       Date:  2003-08-24       Impact factor: 28.824

10.  An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling.

Authors:  Britta J Eickholt; Frank S Walsh; Patrick Doherty
Journal:  J Cell Biol       Date:  2002-04-15       Impact factor: 10.539

View more
  82 in total

Review 1.  Collapsin response mediator proteins regulate neuronal development and plasticity by switching their phosphorylation status.

Authors:  Naoya Yamashita; Yoshio Goshima
Journal:  Mol Neurobiol       Date:  2012-02-18       Impact factor: 5.590

2.  Collapsin response mediator proteins (CRMPs) are a new class of microtubule-associated protein (MAP) that selectively interacts with assembled microtubules via a taxol-sensitive binding interaction.

Authors:  Pao-Chun Lin; Perry M Chan; Christine Hall; Ed Manser
Journal:  J Biol Chem       Date:  2011-09-27       Impact factor: 5.157

3.  Fyn promotes phosphorylation of collapsin response mediator protein 1 at tyrosine 504, a novel, isoform-specific regulatory site.

Authors:  Gwen R Buel; John Rush; Bryan A Ballif
Journal:  J Cell Biochem       Date:  2010-09-01       Impact factor: 4.429

4.  Boosting CNS axon regeneration by harnessing antagonistic effects of GSK3 activity.

Authors:  Marco Leibinger; Anastasia Andreadaki; Renate Golla; Evgeny Levin; Alexander M Hilla; Heike Diekmann; Dietmar Fischer
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

5.  Nonprimed and DYRK1A-primed GSK3 beta-phosphorylation sites on MAP1B regulate microtubule dynamics in growing axons.

Authors:  Timothy M E Scales; Shen Lin; Michaela Kraus; Robert G Goold; Phillip R Gordon-Weeks
Journal:  J Cell Sci       Date:  2009-06-23       Impact factor: 5.285

6.  (S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5.

Authors:  Aubin Moutal; Liberty François-Moutal; Samantha Perez-Miller; Karissa Cottier; Lindsey Anne Chew; Seul Ki Yeon; Jixun Dai; Ki Duk Park; May Khanna; Rajesh Khanna
Journal:  Mol Neurobiol       Date:  2015-04-07       Impact factor: 5.590

7.  Ablation of calcineurin Aβ reveals hyperlipidemia and signaling cross-talks with phosphodiesterases.

Authors:  Hee Yun Suk; Chen Zhou; Teddy T C Yang; Hong Zhu; Raymond Y L Yu; Opeyemi Olabisi; XiaoYong Yang; Deborah Brancho; Ja-Young Kim; Philipp E Scherer; Philippe G Frank; Michael P Lisanti; John W Calvert; David J Lefer; Jeffery D Molkentin; Alessandra Ghigo; Emilio Hirsch; Jianping Jin; Chi-Wing Chow
Journal:  J Biol Chem       Date:  2012-12-20       Impact factor: 5.157

8.  CNP/cGMP signaling regulates axon branching and growth by modulating microtubule polymerization.

Authors:  Caihong Xia; Minh Nguyen; Amy K Garrison; Zhen Zhao; Zheng Wang; Calum Sutherland; Le Ma
Journal:  Dev Neurobiol       Date:  2013-06-24       Impact factor: 3.964

9.  Hierarchical CRMP2 posttranslational modifications control NaV1.7 function.

Authors:  Erik T Dustrude; Aubin Moutal; Xiaofang Yang; Yuying Wang; May Khanna; Rajesh Khanna
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-08       Impact factor: 11.205

10.  Dynamin I phosphorylation by GSK3 controls activity-dependent bulk endocytosis of synaptic vesicles.

Authors:  Emma L Clayton; Nancy Sue; Karen J Smillie; Timothy O'Leary; Nicolai Bache; Giselle Cheung; Adam R Cole; David J Wyllie; Calum Sutherland; Phillip J Robinson; Michael A Cousin
Journal:  Nat Neurosci       Date:  2010-06-06       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.